Since its inception, bio-storage technology has been considered to hold the secret to electronic immortality.
In the two years since China first released its biological storage server, many newly released science fiction works have taken biological storage technology as their starting point, imagining that in the future, human souls would be uploaded to biological storage servers.
In fact, souls and memories can indeed be uploaded, but this cannot be done through biological storage technology.
Moreover, even if the soul and memories are uploaded, immortality cannot be achieved.
"Mr. Li, the results of the first batch of clinical trials are very good, even exceeding our expectations."
The compound composed of these five small molecules has an extremely good effect on adult cm proliferation and heart regeneration.
It can also play a role in preventing coronary artery blockage and precordial squeezing pain.
This is a phase one clinical trial report, a progress report up to this point. You can take a look when you have time.
After handing the report to Li Miaomiao, Wang Jinsong left her office.
In fact, the relevant processes could be completed entirely within the internal office system, with progress reports and work results sent to Li Miaomiao via corporate email.
However, in order to leave a direct impression on the leader and explain how effective their work is.
Face-to-face meetings are always more persuasive than emails and are more likely to leave a lasting impression on leaders.
Especially now that so many innovative drug R&D teams have pipelines, only their group's new drug has reached the clinical trial stage.
Regardless of the type of company you work for, you need to be able to communicate effectively as well as perform tasks. If you can only perform tasks, you won't get promoted.
Even if it's just to secure more resources for your subordinates and assign fewer low-performance evaluation indicators at the end of the year, you still need to report your work to your superiors more often.
As a returnee from overseas, Wang Jinsong had suffered several losses because he didn't understand this principle before.
Therefore, even if I don't want to, I will still do it now.
Zheng Li generally doesn't meet with them, except at the annual meeting where he will give a speech via remote video connection.
Apart from that, even frontline employees and middle managers have no chance to meet Zheng Li.
The only way they could contact Zheng Li was through email.
Every employee of Kechuang Biotechnology can send emails to Zheng Li, and the emails will be categorized and processed by staff from the Chairman's Secretariat.
Reply, forward to relevant individuals, or show to Zheng Li via email.
In Zheng Li's view, there is absolutely no need to set up a department like a secretariat, as the artificial intelligence of the bio-cloud can perfectly handle these tasks.
To avoid appearing unusual, the company set up a secretariat only after it had grown significantly.
Unlike Zheng Li, Li Miaomiao is a mid-level employee who can schedule a time to communicate with her privately through the internal system.
Li Miaomiao's secretary will make arrangements according to her wishes.
Li Miaomiao listened attentively to Wang Jinsong's conversation because he was not boring and could clearly describe their work in language she could understand.
This is not easy, because the cutting-edge field of biomedicine is too specialized, and it takes a lot of skill from the presenter to make the layman understand.
However, this is also thanks to Li Miaomiao's improved thinking ability.
Even if it were Li Miaomiao before she used the magic brain, she would have some difficulty understanding it.
Besides the company's executives, the shareholders who hold shares in Scitech Biotechnology are the most concerned about the company's innovative drug research and development progress.
They are even more concerned about the clinical trial results of innovative drugs than the executives at Scitech Biotech who are not in charge of the innovative drug line.
Does anyone know how well the MSCI-type drug developed by Kechuang Bio has performed in clinical trials?
If this drug performs well in clinical trials, then the market value of Kechuang Bio deserves to rise to another level.
Previously, although Kechuang Bio was a leading company with a market value of trillions, it was actually extremely dependent on its founder, Zheng Li.
Zheng Li is only twenty-five years old, which is the golden age for scientific research.
At least until I'm fifty, I have at least twenty-five years left.
However, I always feel that there are risks in a research-based enterprise that relies on one person.
If Kechuang Bio makes a breakthrough in the field of innovative drugs, it will prove that Kechuang Bio's R&D team is trustworthy, adding an extra layer of insurance to Kechuang Bio's scientific research capabilities.
Whether from the official response from the board secretary of Kechuang Biotechnology or the speeches of Kechuang Biotechnology executives on different occasions, it can be seen that Zheng Li has hardly been involved in the research and development of innovative drugs.
The drug that Kechuang Bio has put into clinical trials this time is mainly for treating heart cell failure.
This is a field with a vast market, and it is a field in which pharmaceutical giants from all over the world invest heavily in competition.
Although Pfizer has made rapid progress in this field of research and development in recent years, Sci-Tech Biotech's innovative drugs still have their merits.
Firstly, this is a drug composed of multiple small molecules, and secondly, it can promote the regeneration of myocardial cells.
According to the "China Cardiovascular Health and Disease Report 2025" released by the Chinese government, the number of people with heart failure in my country last year was around ten million.
What a vast market this could be if MSCI performs well in clinical practice!
More important than the market itself is the successful development of Kechuang Bio's R&D team.
There are also sorcerers behind Pfizer, which has led to their drug development progressing far beyond expectations.
In fact, America has been increasing its R&D investment in the biomedical field.
Especially after the arrival of the mages, America devoted half of its mages to the field of biomedicine.
This chapter is not finished yet. Please click on the next page to continue reading the exciting content!
Continue read on readnovelmtl.com
